Ayoade Akere, MD
Family Medicine · Chicago, ILNPI 1538179379
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,344 of the $4,906 with a category attached, or 68.2%. 10 manufacturers reported payments, led by Merck at 48.2% of the total. Reporting peaked in 2023 at $2,417 and has fallen 57.2% since, to $1,035 in 2025. Among family medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $136.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2K
- Shionogi Inc$1K
- Novartis$889
- Preventric Diagnostics, Inc.$261
- Kowa Pharmaceuticals America, Inc.$124
- GSK$93
- plus $75 from 4 others
Across 109 payments — averaging $4509.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Evofem Biosciences, Inc.$238K
- AstraZeneca$76K
- GSK$73K
- Sanofi Pasteur Inc.$40K
- Eli Lilly$36K
- Romark Laboratories, LC$18K
- plus $10K from 2 others
What the payments were for
- Travel & lodging$3,34468%
- Food & beverage$1,56232%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 16 | $2,363 |
| Shionogi Inc | 3 | $1,101 |
| Novartis | 5 | $889 |
| Preventric Diagnostics, Inc. | 2 | $261 |
| Kowa Pharmaceuticals America, Inc. | 1 | $124 |
| GSK | 5 | $93 |
| Seqirus USA Inc | 1 | $22 |
| Amgen | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,906 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 12 | $11,482 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 16 | $2,806 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $2,171 |
| Nifedipine ErNifedipine | 25 | $1,226 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $969 |
| Gabapentin | 68 | $805 |
| Amlodipine Besylate | 131 | $724 |
| Metoprolol Succinate | 34 | $667 |
| Tamsulosin Hcl | 33 | $636 |
| Fluticasone Propionate | 30 | $625 |
| Atorvastatin Calcium | 84 | $607 |
| Enalapril Maleate | 24 | $533 |
| Naproxen | 68 | $365 |
| Triamcinolone Acetonide | 21 | $360 |
| Lisinopril | 33 | $328 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Chicago
- Frank PhillipsChicago$1.6M
- Bradley TorphyChicago$1.3M
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
- Igor AltmanChicago$64K
- James DelisChicago$31K
- Tatiana BatistaChicago$26K
- Wen Ho YangChicago$26K
- Abdulmassih AbdulmassihChicago$24K
- Andrew PavlatosChicago$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.